scispace - formally typeset
D

Dirk A. E. Dobbelaere

Researcher at University of Bern

Publications -  68
Citations -  3563

Dirk A. E. Dobbelaere is an academic researcher from University of Bern. The author has contributed to research in topics: Theileria parva & Theileria. The author has an hindex of 34, co-authored 68 publications receiving 3374 citations.

Papers
More filters
Journal ArticleDOI

Effect of buparvaquone on the expression of interleukin 2 receptors in Theileria annulata-infected cells.

TL;DR: Theileria annulata-infected cells were cultured in the presence or absence of human recombinant interleukin 2 and this growth factor proved to be capable of enhancing the growth of the infected cells: its effect was marked, particularly when the cells were seeded at low densities, and it varied from cell line to cell line.
Journal ArticleDOI

Isolation and characterization of RNA from the intracellular parasite Theileria parva.

TL;DR: It is concluded that the low number of parasite specific translation products in the mRNA from infected lymphocytes and the lowNumber of parasite proteins detected in isolated schizonts reported previously is due to the low abundance of the parasite transcripts rather than a lownumber of expressed parasite genes.
Journal ArticleDOI

Characterisation of gp34, a GPI-anchored protein expressed by schizonts of Theileria parva and T. annulata.

TL;DR: GP34, a GPI-anchored protein that is expressed on the surface of the schizont of the transforming intracellular parasite Theileria is characterised.
Journal ArticleDOI

Partial sequence of the equine immunoglobulin epsilon heavy chain cDNA.

TL;DR: In order to isolate a part of the immunoglobulin E (IgE) heavy chain cDNA of the horse, primers have been designed based upon well conserved sequences in humans, sheep and rats.
Journal ArticleDOI

Transfection of live, tick derived sporozoites of the protozoan Apicomplexan parasite Theileria parva.

TL;DR: This is the first step towards a stable infection method of T. parva sporozoites, making use of a new generation transfection device, and the long run, transfected parasites might become an alternative way to induce immunity without clinical signs.